15 data-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"https:"-"Dr"-"P" positions at Center for Biologics Evaluation and Research (CBER) in United States

FDA Data Science Fellowship - Bioinformatics and AI/Machine Learning

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

scientific data, including large-scale omics datasets, within high-performance computing (HPC) environments. Learning Objectives: Under the guidance of a mentor, you will gain skills in and learn to: Develop

FDA Computer Science Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

systems that manage scientific and regulatory information. The fellow will collaborate with cross-functional teams to translate complex requirements into intuitive and accessible user interfaces. Learning

FDA Research Opportunity - Immune Responses to Influenza Vaccines

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

multiple techniques including multiplex assays, virus neutralization, Plasmon Surface Resonance machines, protein production, and more Learn skills in data analysis software including statistical software

FDA Fellowship - Development and Evaluation of Gene Therapy for Rare Neuromuscular and Neurological Diseases

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

will generate critical safety and efficacy data to inform regulatory evaluation of these emerging therapeutic modalities. Learning Objectives: If selected, you will have the opportunity to: Develop

FDA Fellowship - Functional Genomics of iPSC Maintenance and Cell Fate Determinations

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

to acquire, summarize and report research data for scientific communication. Gain regulatory science knowledge relevant to cellular and gene therapy products. Mentor: The mentor for this opportunity is Zhaohui

FDA Optimization Modeling to Support Benefit-Risk Assessment Fellowship

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

, which could include Bayesian methodologies and use of artificial intelligence to systematically integrate available information for evolving benefit-risk assessment. The goal is to tackle the major

FDA Fellowship - Understanding the Role of the Manufacturing Microenvironment on the Safety and Efficacy of Cellular Therapies

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page  of the program website for information about the valid immigration statuses

FDA Fellowship - Developing Novel Strategies to Improve Safety, Efficacy and Quality of Gene Therapy Products

Center for Biologics Evaluation and Research (CBER) | Southern Md Facility, Maryland | United States | about 13 hours ago

cultures, 3D models better recapitulate the complex tissue architecture, cell-cell interactions, and microenvironmental conditions found in vivo, potentially providing more physiologically relevant data

FDA Research Opportunity in Developing Methods for Efficient Gene Editing in Hematopoietic Stem Cells (HSCs)

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

Residents (LPR), and foreign nationals. Non-U.S. citizen applicants should refer to the Guidelines for Non-U.S. Citizens Details page  of the program website for information about the valid immigration

FDA Focus Towards More Efficient Factor VIII Drug Products to Improve the Treatment of Hemophilia A

Center for Biologics Evaluation and Research (CBER) | Silver Spring, Maryland | United States | about 13 hours ago

obligation to protect and not to further disclose or use non-public information.